[하파크리스틴 매각]① '마녀공장 부진' 케이엘앤파트너스의 투자 속내는

As K-beauty matures across Asia, PE-backed companies are forced into adjacent categories to offset weakening performance—even when structural fit is questionable. This acquisition reveals both growth imperative and underlying financial stress, with Japan's slowing beauty market compelling riskier diversification into unrelated business models. The regulatory and distribution gaps between cosmetics and medical devices make realizing claimed synergies inherently difficult.